Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:

Monday, December 5, 2016

5 Articles to Watch from the European Stroke Journal - Professor Bo Norrving Editor-in-Chief

If Professor Bo Norrving did anything useful for survivors when he was president of the World Stroke Organization it is impossible to tell. I wonder how many stroke survivors he talked to personally?
Email from SAGE publishing.
What are the long-term risk factors for patients that suffer stroke at a young age?
How effective is tranexamic acid for improving clinical outcome following intracerebral haemorrhage?
Does a change in antiplatelet regimen increase risk of recurrent ischaemic stroke?
These are some of the questions that recent papers from the journal have tackled.

As Editor-in-Chief for the European Stroke Journal, I am really proud of the innovative research recently published in the journal.
Five recent papers from the journal really caught my attention. As they are definitely papers to look out for, I really wanted to share them with you.
That’s why I we have freed access to these papers until December 31st*.
Get instant access to these papers now:
  1. How many stroke patients might be eligible for mechanical thrombectomy?
  2. The very long-term risk and predictors of recurrent ischaemic events after a stroke at a young age: The FUTURE study
  3. A role for autophagy in carotid atherosclerosis
  4. Antiplatelet therapy following ischaemic stroke – Continue or change pre-existing therapy?
  5. Treatment of intracerebral haemorrhage with tranexamic acid – A review of current evidence and ongoing trials
Happy reading,
Professor Bo Norrving
p.s. Enjoyed these papers?
Sign up for our table of content alerts to stay updated on all fields of clinical stroke research published in the journal, including clinical trials, epidemiology, prevention, diagnosis, acute management, guidelines, rehabilitation, stroke care, societal impact and much more.

No comments:

Post a Comment